Hormones and the neovascularization process: role of angiotensin II.
Silvestre
Jean-Sébastien
JS
INSERM U541, Hôpital Lariboisière, 41 bvd de la chapelle, 75475 Paris 10, France. jean-sebastien.silvestre@larib.inserm.fr
Lévy
Bernard I
BI
D000804:Angiotensin II / Q000502:physiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology; D002454:Cell Differentiation; D015687:Cell Hypoxia; D004730:Endothelium, Vascular / Q000166:cytology* / Q000502:physiology*; D006801:Humans; D007249:Inflammation; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D012084:Renin-Angiotensin System; D013234:Stem Cells / Q000166:cytology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II